Clinical Trial Update: Metformin in Stage IV Lung Adenocarcinoma [Phase 2]

View source ↗

Summary

A Phase 2 trial of metformin in stage IV non-small cell lung cancer (lung adenocarcinoma) has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Adenocarcinoma
• Non-small Cell Lung Cancer

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: National Cheng-Kung University Hospital | Conditions: Non-small Cell Lung Cancer | Phase 2 | Status: TERMINATED